Clinical Trial

CorWave LVAS FIH Study

Recruiting
View on ClinicalTrials.gov →
Summary
The study is a prospective, multi-center, non-randomized trial to evaluate the safety and effectiveness of the CorWave LVAS for the treatment of advanced heart failure patients.
Protocol Amendment History 1 change
notable Primary completion pushed: 2026-05 -> 2026-08 2026-08-04
Trial Details
NCT Number NCT06907017
Lead Sponsor CorWave
Conditions Advanced Heart Failure
Enrollment 20 participants
Start Date 2025-05-06
Primary Completion 2026-08 (estimated)
Study Completion 2028-05 (estimated)
Updated on ClinicalTrials.gov 2026-08-03